Tracking Antibiotic Levels in ICU Brain Injury Patients
Part of Brain & nervous system, Injuries & trauma clinical trials.
This study monitors the amount of certain antibiotics in the blood of patients with acute brain injury in the intensive care unit. It aims to make sure the antibiotics are at the right level to fight infection, especially in patients whose kidneys are clearing drugs faster than normal.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You are in the intensive care unit for a sudden brain injury.
- Your kidneys are clearing drugs faster than usual (confirmed by a urine test).
- You are receiving one of these antibiotics: amoxicillin/clavulanic acid, cefotaxime, piperacillin/tazobactam, cefepime, or meropenem.
- You have health insurance coverage.
- You are not expected to live less than 24 hours.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at why some antibiotics given through a vein may reach infections differently in very sick children. It aims to make sure medicines are given in the best way to help children in the intensive care unit recover.
This study looks at how gut bacteria affect severe infections in the ICU. It tests whether the microbiome can be a source of sepsis and a target for treatment. If you are critically ill or a long-term sepsis survivor, you might help find new ways to prevent infections.
This trial measures how quickly the kidneys clear drugs in patients with serious brain conditions like stroke or meningitis. It may help doctors adjust medicine doses for better treatment.
This trial studies how a common antibiotic (ceftriaxone) is processed in the body of brain-injured patients on breathing machines, to find the best dose for preventing early pneumonia. It may help improve care and outcomes for people with serious brain injuries.
This study looks at how doctors can better monitor antibiotic levels in the blood of intensive care patients with severe infections (sepsis or septic shock). The goal is to see if adjusting antibiotic doses based on these levels improves recovery.
This trial tests a new way to quickly measure antibiotic levels in the blood of ICU patients, so doctors can adjust the dose for each person. It aims to make antibiotic therapy more effective and safer.
Hear when a new Critical Illness trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.